AVNS
Price
$19.89
Change
+$0.30 (+1.53%)
Updated
Mar 27, 6:59 PM EST
34 days until earnings call
NEOG
Price
$15.46
Change
+$0.46 (+3.07%)
Updated
Mar 27, 6:59 PM EST
12 days until earnings call
Ad is loading...

Compare trend and price AVNS vs NEOG

Header iconAVNS vs NEOG Comparison
Open Charts AVNS vs NEOGBanner chart's image
Avanos Medical
Price$19.89
Change+$0.30 (+1.53%)
Volume$21.04K
CapitalizationN/A
Neogen
Price$15.46
Change+$0.46 (+3.07%)
Volume$590.82K
CapitalizationN/A
View a ticker or compare two or three
AVNS vs NEOG Comparison Chart

Loading...

AVNSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEOGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AVNS vs. NEOG commentary
Mar 28, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVNS is a Buy and NEOG is a Hold.

COMPARISON
Comparison
Mar 28, 2024
Stock price -- (AVNS: $19.90 vs. NEOG: $15.46)
Brand notoriety: AVNS and NEOG are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AVNS: 57% vs. NEOG: 65%
Market capitalization -- AVNS: $919.46M vs. NEOG: $3.35B
AVNS [@Medical Specialties] is valued at $919.46M. NEOG’s [@Medical Specialties] market capitalization is $3.35B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $7.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVNS’s FA Score shows that 1 FA rating(s) are green whileNEOG’s FA Score has 0 green FA rating(s).

  • AVNS’s FA Score: 1 green, 4 red.
  • NEOG’s FA Score: 0 green, 5 red.
According to our system of comparison, AVNS is a better buy in the long-term than NEOG.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVNS’s TA Score shows that 6 TA indicator(s) are bullish while NEOG’s TA Score has 4 bullish TA indicator(s).

  • AVNS’s TA Score: 6 bullish, 2 bearish.
  • NEOG’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AVNS is a better buy in the short-term than NEOG.

Price Growth

AVNS (@Medical Specialties) experienced а +1.84% price change this week, while NEOG (@Medical Specialties) price change was -0.90% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.09%. For the same industry, the average monthly price growth was -0.31%, and the average quarterly price growth was +3.80%.

Reported Earning Dates

AVNS is expected to report earnings on May 01, 2024.

NEOG is expected to report earnings on Jul 23, 2024.

Industries' Descriptions

@Medical Specialties (+1.09% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
A.I.dvisor published
a Summary for AVNS with price predictions.
OPEN
A.I.dvisor published
a Summary for NEOG with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
NEOG($3.35B) has a higher market cap than AVNS($919M). NEOG has higher P/E ratio than AVNS: NEOG (154.60) vs AVNS (51.86). AVNS YTD gains are higher at: -11.280 vs. NEOG (-23.123). NEOG has higher annual earnings (EBITDA): 189M vs. AVNS (53.2M). NEOG has more cash in the bank: 230M vs. AVNS (87.7M). AVNS has less debt than NEOG: AVNS (209M) vs NEOG (889M). NEOG has higher revenues than AVNS: NEOG (919M) vs AVNS (673M).
AVNSNEOGAVNS / NEOG
Capitalization919M3.35B27%
EBITDA53.2M189M28%
Gain YTD-11.280-23.12349%
P/E Ratio51.86154.6034%
Revenue673M919M73%
Total Cash87.7M230M38%
Total Debt209M889M24%
FUNDAMENTALS RATINGS
AVNS vs NEOG: Fundamental Ratings
AVNS
NEOG
OUTLOOK RATING
1..100
1953
VALUATION
overvalued / fair valued / undervalued
1..100
89
Overvalued
87
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9189
PRICE GROWTH RATING
1..100
6175
P/E GROWTH RATING
1..100
2268
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEOG's Valuation (87) in the Medical Specialties industry is in the same range as AVNS (89). This means that NEOG’s stock grew similarly to AVNS’s over the last 12 months.

NEOG's Profit vs Risk Rating (100) in the Medical Specialties industry is in the same range as AVNS (100). This means that NEOG’s stock grew similarly to AVNS’s over the last 12 months.

NEOG's SMR Rating (89) in the Medical Specialties industry is in the same range as AVNS (91). This means that NEOG’s stock grew similarly to AVNS’s over the last 12 months.

AVNS's Price Growth Rating (61) in the Medical Specialties industry is in the same range as NEOG (75). This means that AVNS’s stock grew similarly to NEOG’s over the last 12 months.

AVNS's P/E Growth Rating (22) in the Medical Specialties industry is somewhat better than the same rating for NEOG (68). This means that AVNS’s stock grew somewhat faster than NEOG’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AVNSNEOG
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
63%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
54%
Momentum
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
72%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
69%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
71%
Advances
ODDS (%)
Bullish Trend 1 day ago
65%
Bullish Trend 8 days ago
66%
Declines
ODDS (%)
Bearish Trend 14 days ago
74%
Bearish Trend 2 days ago
70%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
55%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 1 day ago
80%
View a ticker or compare two or three
Ad is loading...
AVNSDaily Signal changed days agoGain/Loss if shorted
 
Show more...
NEOGDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
EAASX34.740.45
+1.31%
Eaton Vance Atlanta Capital SMID-Cap A
LLINX16.550.08
+0.49%
Longleaf Partners International
STRGX64.78N/A
N/A
Sterling Capital MdCp Relatv Val Instl
PINDX17.61N/A
N/A
Pioneer Disciplined Growth A
CGCIX12.59-0.02
-0.16%
Calamos Global Opportunities I

AVNS and

Correlation & Price change

A.I.dvisor indicates that over the last year, AVNS has been loosely correlated with RVTY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if AVNS jumps, then RVTY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AVNS
1D Price
Change %
AVNS100%
+1.58%
RVTY - AVNS
49%
Loosely correlated
+1.92%
VREX - AVNS
46%
Loosely correlated
+1.91%
OPK - AVNS
44%
Loosely correlated
+5.94%
TFX - AVNS
37%
Loosely correlated
+3.46%
AORT - AVNS
35%
Loosely correlated
+5.36%
More

NEOG and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEOG has been loosely correlated with KIDS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if NEOG jumps, then KIDS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEOG
1D Price
Change %
NEOG100%
+3.07%
KIDS - NEOG
43%
Loosely correlated
+10.34%
CDNA - NEOG
42%
Loosely correlated
+10.14%
CERS - NEOG
41%
Loosely correlated
+3.16%
CRL - NEOG
39%
Loosely correlated
+1.48%
BAX - NEOG
39%
Loosely correlated
+2.77%
More